Elevance Health — Apr 17, 2025 release

Item 7.01 - Regulation FD Disclosure. Elevance Health, Inc. (the “Company”) will release its first quarter 2025 financial results on April 22, 2025. The Company expects to report first quarter GAAP shareholders’ net income of $9.61 per diluted share, including approximately $2.36 per diluted share of net unfavorable items. Excluding these items, adjusted shareholders’ net income was $11.97 per diluted share. First quarter results reflect medical cost trends that developed in line with the Company’s expectations, including in its Medicare Advantage business. While cost trends in Medicare Advantage remain elevated, the Company’s first quarter experience was consistent with its expectations and pricing. In addition, the Company continues to expect full-year 2025 Medicare Advantage membership of 2,200 to 2,250 thousand members, in line with the guidance provided in its Fourth Quarter 2024 Earnings Release, dated January 23, 2025. Based on these results and the Company’s outlook, the Company intends to reaffirm shareholders’ adjusted net income guidance for full year 2025 to be $34.15 to $34.85 per diluted share. The Company will provide additional details on its first quarter financial results and full year outlook when it reports results on April 22, 2025. None of the information furnished in Item 2.02 and Item 7.01 hereto shall be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended